Niki BioSolutions, Inc. (NIKI): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$431.4K
Year ended 2023-12-31
$1.54M2021-12-31: $1.54M2022-12-31: $1.30M2023-12-31: $431.4K$431.4K
2021-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$431.4K-66.7%2026-03-27, From 2023-01-01
2022-12-31$1.30M-15.9%2025-04-30, From 2022-01-01
2021-12-31$1.54Mn/a2024-04-30, From 2021-01-01